Shuiping Gao
No.270 Dong'An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Loss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4.
Journal: International journal of molecular sciences
Published: July 14, 2026
Cancer-Associated Fibroblasts Functions as Multifunctional Architects of the Tumor Stroma and Represent Emerging Therapeutic Vulnerabilities.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 31, 2025
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer.
Journal: Cell reports. Medicine
Published: April 17, 2025
Correction: Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma.
Journal: BMC medicine
Published: April 14, 2025
Phase 1b study of first-line fuzuloparib combined with modified FOLFIRINOX followed by fuzuloparib maintenance monotherapy in pancreatic adenocarcinoma.
Journal: BMC medicine
Published: January 18, 2024
Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours.
Journal: NPJ breast cancer
Published: October 18, 2022
Hsa_circ_0001944 enhanced GSPT1 expression via sponging miR-498 to promote proliferation and invasion of gastric cancer.
Journal: Journal of clinical laboratory analysis
Published: August 01, 2022
Phase I study of pucotenlimab (HX008), an anti-PD-1 antibody, for patients with advanced solid tumors.
Journal: Therapeutic advances in medical oncology
Published: November 25, 2020
Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene.
Journal: Acta biochimica et biophysica Sinica
Published: January 29, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026